IVIG induces dose-dependent amelioration of ITP in rodent models
Blood, The Journal of the American Society of Hematology, 2003•ashpublications.org
12. Willemze R, Suciu S, Archimbaud E et al. A randomized phase II study on the effects of 5-
Aza-2-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed
acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). Leukemia.
1997; 11 (suppl 1): 24-27.
Aza-2-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed
acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). Leukemia.
1997; 11 (suppl 1): 24-27.
12. Willemze R, Suciu S, Archimbaud E et al. A randomized phase II study on the effects of 5-Aza-2-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). Leukemia. 1997; 11 (suppl 1): 24-27.
ashpublications.org